Ina Sternberger

Ina Sternberger has extensive work experience in the pharmaceutical industry, with a focus on in vitro biology and drug development. Ina started their career as a PhD student at Cancer Research UK, where they assessed the molecular mechanism of clathrin coat formation in neuroendocrine cells. Ina then worked as a postdoc at Aventis Pharma before joining Keyneurotek as a Scientist, where they developed an ex vivo tauopathy model in organotypic brain slice cultures.

In 2008, Ina joined Evotec as a Senior Research Scientist, where they served as a project manager in preclinical drug development. Ina'sexpertise included high content screening, primary cell culture, cellular assay development, and high throughput screening. Ina gradually progressed within the company, becoming Vice President of In vitro pharmacology and later the Group Leader in vitro pharmacology.

In 2018, Ina was promoted to the role of Senior Vice President of In vitro Biology at Evotec, where they headed the In vitro Biology Division. Ina'sresponsibilities included managing the In vitro Pharmacology, Huntington's research and Translational Sciences, and High content imaging and analysis departments. In 2019, they took on the role of Senior Vice President In vitro Biology and became the site head at Evotec's HQ in Hamburg, where they managed the site's operations and support functions and led the conceptual design of a new laboratory building.

In their most recent role at Evotec, starting in March 2021, Ina became the SVP Head of Strategic Initiatives and Project Management. Ina led global, multidisciplinary teams in building and expanding multimodality drug development approaches in RNA modulation and antibody-drug conjugates. Ina'sresponsibilities included developing recommendations for the executive board, proposing strategic collaborations and investments, and defining unique selling points for the business development team. In addition, they built and managed a global project management team for the Integrated Drug Discovery unit, supported budgeting efforts, and enhanced the governance structure for Discovery Development continuum.

Overall, Ina Sternberger has demonstrated strong leadership skills, strategic thinking, and expertise in drug development throughout their career in the pharmaceutical industry.

Ina Sternberger obtained a Ph.D. in biochemistry from UCL, where they studied from 1998 to 2003. Ina also earned a degree in Diplom-Biologin in biochemistry from The University of Göttingen, where their studies took place from 1992 to 1998.